Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice

REFERENCES

• Barioglio, S. R., Lacuara, J. L. & Paguni-Oliva, P. (1987). Effects of clomipramine upon motility of Trypanosoma cruzi. Journal of Parasitology, 73, 451–452.
   PubMed Web of Science ®Google Scholar
• Benson, T. J., McKie, J. H., Garforth., Borges, A., Fairlamb, H., Bergdolt, B. A., Tanowitz, H. B., Wittner, M., Morris, S. A., Bilezikian, J. P., Moreno, A. P. & Spray, D. C. (1994). Trypanosoma cruzi: effects of infection on receptor-mediated chronotropy and Ca2+ mobilisation in rat cardiac myocytes. Experimental Parasitology, 78, 149–160.
   PubMed Web of Science ®Google Scholar
• Borges, A., Cunninghan, M. L., Tovard, J. & Fairlamb, A. H. (1995). Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. European Journal of Biochemistry, 228, 745–752.
   PubMedGoogle Scholar
• Brodde, O. E. (1996). β-Adrenergic receptors in failing human myocardium. Basic Research in Cardiology, 91, 35–40.
   PubMed Web of Science ®Google Scholar
• Bronia, D. H., Pereira, B. M. I., Luján, H. D., Fretes, R. E., Fernández, A. R. & Paglini, P. (1999). Ganglioside treatment of acute Trypanosoma cruzi infection in mice promotes long-term survival and parasitological cure. Annals of Tropical Medicine and Parasitology, 93, 341–350.
   PubMed Web of Science ®Google Scholar
• Castro, J. A. & Díaz de Toranzo, E. G. (1988). Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). Biomedical and Environmental Sciences, 1, 19–33.
   PubMedGoogle Scholar
• De Castro, S. L. (1993). The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Tropica, 53, 83–98.
   PubMed Web of Science ®Google Scholar
• Douglas, K. T. (1995). Phenothiazines as trypanothione reductase inhibitors. In Biological and Chemical Aspects of Thiazines and Analogs, Vol. 1, eds Barbé, J., Keyser, H. & Soyfer, J. C. pp. 317–328. San Gabriel, CA: Enlight Associated.
   Google Scholar
• Enders, J. E., Paglini, P., Fernández, A. R., Marco, F. & Palma, J. A. (1995). Cardiac beta receptor in experimental Chagas disease. Revista do Instituto de Medicina Tropical de São Paulo, 37, 59–62.
   PubMedGoogle Scholar
• Engels, J. C. & McKerrow, J. H. (1995). Physiological and ultrastructural changes induced by cysteine proteinase inhibitors in Trypanosoma cruzi. Memórias do Instituto Oswaldo Cruz, 90, 43–44.
   PubMed Web of Science ®Google Scholar
• Fairlamb, A. H. & Cerani, A. (1992). Metabolism and functions of trypanothione in the Kinetoplastida. Annual Review of Microbiology, 46, 695–729.
   PubMed Web of Science ®Google Scholar
• Fernández, A. R., Enders, J. E., Paglini, P., Rivarola, W. & Palma, J. A. (1994). Chagas cardiomiopathy: functional correlations with morphological and biochemical changes. Memórias do Instituto Oswaldo Cruz, 89, 66.
   Web of Science ®Google Scholar
• Fernández, A. R., Enders, J. E., Rivarola, W., Paglini, P. & Palma, J. A. (1995). Acute Chagas' disease: study of beta receptors in two experimental models. Memórias do Instituto Oswaldo Cruz, 90, 79.
   Web of Science ®Google Scholar
• Fernández, A. R., Fretes, R., Rubiales, S., Lacuara, J. L. & Paguni-Oliva, P. (1997). Effects of prometazine on the viability of T. cruzi. Medicina (Buenos Aires), 57, 59–62.
   PubMed Web of Science ®Google Scholar
• Franke de Cazzulo, B. M., Bernacchi, A., Esteva, M. I., Ruiz, A. M., Castro, J. A. & Cazzulo, J. J. (1998). Trypanocidal effect of SKF525A, Proadifen, on different developmental forms of Trypanosoma cruzi. Medicina (Buenos Aires), 58, 415–418.
   PubMed Web of Science ®Google Scholar
• Gea, S., Gruppi, A., Cerban, F., Pistoresi-Palencia, M. C. & Vottero-Cima, E. (1992). Immune response in mice immunized with acidic antigenic fractions from Trypanosoma cruzi cytosol. Revista do Instituto de Medicina Tropical de Sao Paulo, 34, 389–394.
   PubMed Web of Science ®Google Scholar
• Gorla, N. B., Ledesma, O. S., Barbieri, G. P. & Larripa, I. B. (1989). Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox. Mutation Research, 224, 263–267.
   PubMed Web of Science ®Google Scholar
• Hunter, W. N. (1995). Structure and mechanism of trypanothione reductase, a target for therapy. Memórias do Instituto Oswaldo Cruz, 90, 45–46.
   PubMed Web of Science ®Google Scholar
• Labriola, C., Sousa, M. & Cazzulo, J. J. (1993). Purification of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography. Biological Research, 26, 101–107.
   PubMedGoogle Scholar
• Lacuara, J. L., Barioglio, S., Paglini-Oliva, P., Bernacchi, A. S., Fernández, A. R., Castro, J. A., Cazzulo, B. M. & Cazzulo, J. J. (1991). Disruption of mitochondrial function as the basis of the trypanocidal effect of trifluoperazine on Trypanosoma cruzi. Experientia, 47, 612–616.
   PubMedGoogle Scholar
• Luján, H., Paglini, P., Fernández, A., Fretes, R., Fidelio, G. & Bronia, D. (1993). Effects of ganglioside on the T. cruzi infection in mice. Life Sciences, 53, 69–73.
   Web of Science ®Google Scholar
• Morello, A. (1988). The biochemistry of the mode of action of drugs and the detoxication mechanism in Trypanosoma cruzi. Comparative Biochemistry and Physiology, 90, 1–12.
   Web of Science ®Google Scholar
• Paglini-Oliva, P., Palma, J. A., González Cremer, M. & Lacuara, J. L. (1984). Acute Chagas disease in the mouse. Contractile response of the isolated myocardium to pharmacological agents. Medicina (Buenos Aires), 44, 371–375.
   PubMed Web of Science ®Google Scholar
• Paglini-Oliva, P., Palma, J. A., González Cremer, M., Segura, E. L. & Lacuara, J. L. (1985). Chronic Chagas disease in the mouse. Contractile response of the isolated myocardium. American Journal of Tropical Medicine and Hygiene, 34, 1149–1152.
   PubMed Web of Science ®Google Scholar
• Paglini-Oliva, P., Fernández, A. R. & Lacuara, J. L. (1987). Pharmacological and contractile response of myocardium of chagasic albino Swiss mice. Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana, 35, 395–401.
   Google Scholar
• Paglini-Oliva, P., Fernandez, A. R., Fretes, R. & Pelsman, A. (1998). Structural, ultrastructural studies and evolution of Trypanosoma cruzi infected mice treated with thioridazine. Experimental and Molecular Pathology, 65, 78–86.
   PubMed Web of Science ®Google Scholar
• Schirmer, R. H., Muller, J. G. & Krauth-Siegel, R. L. (1995). Disulfide reductase inhibitors as chemotheraputic agents: the design of drugs for trypanosomiasis and malaria. Angewandte Chemie—International Edition in English, 34, 141–154.
   Web of Science ®Google Scholar
• Segura, M. A., Molina de Raspi, E. & Basombrio, M. A. (1994). Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanocidal treatment. Memórias do Instituto Oswaldo Cruz, 89, 213–216.
   PubMed Web of Science ®Google Scholar
• Segura, M. A., Barberá, L. C., Ramos, F. & Basombrio, M. A. (1996). Regression of antibodies and resistance to reinfection in mice inoculated with an attenuated Trypanosoma cruzi strain and treated with nifurtimox. Memórias do Instituto Oswaldo Cruz, 91 (Suppl.), 316.
   Google Scholar
• World Health Organization (1991). Tropical Disease Progress in Research 1989–1990. Tenth Program Report of the World Health Organization. Geneva: WHO.
   Google Scholar